Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Diabetologia 49(2):25360 Drucker DJ, Habener JF, Holst JJ (2017) Discovery, characterization, and clinical development of the glucagon-like peptides
Among patients with pre-transplant diabetes, outcomes aligned with the main findings
Liraglutide treatment is associated with a low frequency and magnitude of antibody formation with no apparent impact on glycemic response or increased frequency of adverse events: results from the liraglutide effect and action in diabetes (LEAD) trials
GLP-1 research compounds are peptides designed to interact with receptors involved in appetite regulation, insulin signaling, gastric emptying, energy metabolism, and glucose homeostasis
10.1007/s10517-018-4074-1 Bull
US$ 22.23
US$ 29.54
US$ 24.38
US$ 22.10
US$ 29.84
